We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$4.56B
AUM Growth
-$316M
Cap. Flow
-$742M
Cap. Flow %
-16.27%
Top 10 Hldgs %
15.49%
Holding
2,634
New
531
Increased
353
Reduced
471
Closed
900

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$26.9M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$24.7M
3
AMZN icon
Amazon
AMZN
+$22.4M
4
INDV icon
Indivior Pharmaceuticals
INDV
+$21.7M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$18M

Top Sells

Rank Stock Value
1
CVII
Churchill Capital Corp VII Class A Common Stock
CVII
+$23.1M
2
WMT icon
Walmart Inc
WMT
+$17.7M
3
BURL icon
Burlington
BURL
+$12.7M
4
ALCE
Alternus Clean Energy Inc
ALCE
+$12.1M
5
GILD icon
Gilead Sciences
GILD
+$11.7M

Sector Composition

Rank Sector Weight
1 Healthcare 9.99%
2 Technology 9.63%
3 Financials 7.8%
4 Industrials 6.22%
5 Consumer Discretionary 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGNX icon
1801
Cognex
CGNX
$10.9B
– –
-5,880
Closed -$291K
CHD icon
1802
Church & Dwight Co
CHD
$23.4B
– –
-12,271
Closed -$1.08M
CHE icon
1803
Chemed
CHE
$7.07B
– –
-500
Closed -$269K
CHGG icon
1804
Chegg
CHGG
$110M
– –
-14,948
Closed -$244K
CIM
1805
Chimera Investment
CIM
$1.04B
– –
-4,688
Closed -$79.3K
CINF icon
1806
Cincinnati Financial
CINF
$27.3B
– –
-2,356
Closed -$264K
CLDX icon
1807
Celldex Therapeutics
CLDX
$2.99B
– –
-19,576
Closed -$704K
CLDX icon
1808
PUT
Celldex Therapeutics
CLDX
$2.99B
– –
-22,500
Closed -$810K
CLFD icon
1809
Clearfield
CLFD
$411M
– –
-39,856
Closed -$1.86M
CLPT icon
1810
ClearPoint Neuro
CLPT
$448M
– –
-11,027
Closed -$93.1K
CMCSA icon
1811
CALL
Comcast
CMCSA
$85B
– –
-75,200
Closed -$2.85M
CMI icon
1812
Cummins
CMI
$87.5B
– –
-1,388
Closed -$332K
CMP icon
1813
Compass Minerals
CMP
$1.23B
– –
-80,122
Closed -$2.75M
CMPX icon
1814
Compass Therapeutics
CMPX
$344M
– –
-26,945
Closed -$88.1K
CMTL icon
1815
Comtech Telecommunications
CMTL
$50.3M
– –
-128,226
Closed -$1.6M
CNC icon
1816
Centene
CNC
$30.7B
– –
-14,981
Closed -$947K
CNXC icon
1817
Concentrix
CNXC
$1.5B
– –
-3,694
Closed -$449K
COLD icon
1818
Americold
COLD
$4.02B
– –
-13,167
Closed -$375K
COLM icon
1819
Columbia Sportswear
COLM
$3.04B
– –
-2,654
Closed -$239K
VISN
1820
PUT
Vistance Networks Inc
VISN
$2.65B
– –
-45,000
Closed -$287K
COO icon
1821
Cooper Companies
COO
$14.1B
– –
-76,840
Closed -$7.17M
CRL icon
1822
Charles River Laboratories
CRL
$11.2B
– –
-4,346
Closed -$877K
CRS icon
1823
Carpenter Technology
CRS
$25.8B
– –
-7,720
Closed -$346K
CRUS icon
1824
Cirrus Logic
CRUS
$6.53B
– –
-3,387
Closed -$370K
CTSH icon
1825
CALL
Cognizant
CTSH
$24.9B
– –
-45,300
Closed -$2.76M
71 72
73
74 75

Similar funds

MAM
Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
IMCOOI
Investment Management Corp of Ontario (IMCO) Toronto, Canada $7.76B AUM 99.29% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return

Boothbay Fund Management's Q2 2023 Portfolio in Review

As of Q2 2023, Boothbay Fund Management held 2,634 positions worth $4.56B, down 6.5% from $4.87B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Boothbay Fund Management withdrew a net $742M in Q2 2023, closing 900 positions and reducing 471 holdings. Its most notable exit was Alternus Clean Energy Inc, an estimated $12.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 10% a quarter earlier, followed by Technology and Financials.

Against the trend, Boothbay Fund Management opened a new position in Indivior Pharmaceuticals worth $21.9M.

  • Boothbay Fund Management's largest Q2 2023 buy was Indivior Pharmaceuticals: 946,208 shares worth $21.9M.
  • Boothbay Fund Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2023, an estimated $26.9M increase.
  • Boothbay Fund Management's biggest Q2 2023 reduction was Churchill Capital Corp VII Class A Common Stock, cutting an estimated $23.1M.
  • Boothbay Fund Management fully exited Alternus Clean Energy Inc in Q2 2023, selling an estimated $12.1M.
  • Boothbay Fund Management's ten largest holdings make up 15% of its $4.56B portfolio in Q2 2023.
  • Boothbay Fund Management opened 531 new positions and closed 900 in Q2 2023.
  • Boothbay Fund Management's portfolio value fell 6.5% quarter-over-quarter to $4.56B.

Based on Boothbay Fund Management's 13F filing for Q2 2023, filed 14 Aug 2023.